The rise of long-term opioid therapy for chronic noncancer pain between 2013 and 2022 despite its limited effectiveness highlights the need for revised primary care pain guidelines. Between 2013 and ...

A primary source investigation into the service history of a Smith & Wesson Victory revolver used by the U.S. Navy in the ...

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

Astegolimab is a fully human anti-ST2 monoclonal antibody designed to bind to the ST2 receptor and block the IL-33 signalling pathway.

The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for deucravacitinib for the treatment of adults with active psoriatic arthritis (PsA).

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

The approved claims resolution procedures set bar dates for claims, which are August 25, 2025 for non-governmental claimants and September 24, 2025 for governmental claimants. Claimants include any ...

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.

GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with ...

The recently released 2025 Unified Tertiary Matriculation Examination (UTME) results by the Joint Admissions and Matriculation Board (JAMB) paint a deeply unsettling picture--not because of who passed ...

In a review and meta-analysis, serious spinal pathologies accounted for 3% of cases of LBP, with higher rates in complex care settings.

Armour 3.0 isn't the only shakeup in Destiny 2 The Edge of Fate, as it also introduces armour set bonuses and new gear tiers ...